works with partners worldwide to improve health outcomes and save lives, through use of pharmaceutical cost-lowering measures including generic competition. We help civil society groups and public agencies overcome patent-based and other drug monopolies. We assess new developments in policy and law, and work with coalition partners to promote game-changing ideas that advance pharmaceutical access and innovation simultaneously. Read more.